Cullinan Oncology LLC
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -79 | -79 | ||
EBITDA | -53,625 | -53,618 | -50,634 | -50,531 |
EBIT | -53,704 | -53,697 | -50,713 | -50,610 |
Net Income | -53,704 | -49,661 | -50,713 | -50,610 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -38,219 | -46,045 | -38,120 | -36,915 |
Cash | 78,640 | 75,081 | 88,332 | 103,335 |
Basic Shares | 61,493 | 59,201 | 59,201 | 59,015 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -311 | -306 | -310 | -93 |
EBITDA | -219,568 | -167,152 | -190,339 | -132,044 |
EBIT | -219,879 | -167,458 | -190,649 | -132,137 |
Net Income | -219,879 | -167,383 | -153,162 | 111,214 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 96,378 | |||
Free Cash Flow | -175,799 | -145,303 | -134,483 | -127,797 |
Cash | 88,332 | 83,005 | 98,434 | 156,152 |
Basic Shares | 59,050 | 53,771 | 41,550 | 46,640 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.81 |
2026-03-31 | -$0.75 |
2025-12-31 | -$0.77 |
2025-09-30 | -$0.77 |